Exact Mass: 562.1111

dTDP-5-dimethyl-L-lyxose

dTDP-5-dimethyl-L-lyxose; dTDP-4-O-demethyl-beta-L-noviose

Gambiriin B1

Gambiriin B3

2-{[6,12-bis(3,4-dihydroxyphenyl)-8,11-dihydroxy-4,13-dioxatricyclo[7.4.0.0³,⁷]trideca-1,3(7),8-trien-5-yl]methyl}benzene-1,3,5-triol

Gambiriin B3 is found in herbs and spices. Gambiriin B3 is isolated from Sanguisorba officinalis (burnet bloodwort). Isolated from Sanguisorba officinalis (burnet bloodwort). Gambiriin B3 is found in tea and herbs and spices.

dTDP-3-O-methyl-beta-L-rhamnose

Gambiriin B2

Physalin H

14-Chloro-5,15-dihydroxy-2,9,26-trimethyl-3,19,23,28-tetraoxaoctacyclo[16.9.1.1~18,27~.0~1,5~.0~2,24~.0~8,17~.0~9,14~.0~21,26~]nonacos-11-ene-4,10,22,29-tetrone

C28H31ClO10 (562.1606)

Physalin H is a physalin. Physalin H is a natural product found in Alkekengi officinarum var. franchetii with data available. Physalin H is found in fruits. Physalin H is from the famine food Physalis angulata (cutleaf ground cherry).

Epifisetinidol-(4beta->8)-catechin

2-(3,4-dihydroxyphenyl)-8-[2-(3,4-dihydroxyphenyl)-3,7-dihydroxy-3,4-dihydro-2H-1-benzopyran-4-yl]-3,4-dihydro-2H-1-benzopyran-3,5,7-triol

Epifisetinidol-(4beta->8)-catechin is found in fruits. Epifisetinidol-(4beta->8)-catechin is a constituent of Pithecellobium dulce (manila tamarino)

3,3',4',5,7-Pentahydroxyflavan(4->8)-3,4',5,7-tetrahydroxyflavan

8-[2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-3,4-dihydro-2H-1-benzopyran-4-yl]-2-(4-hydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3,5,7-triol

3,3,4,5,7-Pentahydroxyflavan(4->8)-3,4,5,7-tetrahydroxyflavan is found in pulses. 3,3,4,5,7-Pentahydroxyflavan(4->8)-3,4,5,7-tetrahydroxyflavan is isolated from azuki bean (Vigna angularis) seeds. Isolated from azuki bean (Vigna angularis) seeds. 3,3,4,5,7-Pentahydroxyflavan(4->8)-3,4,5,7-tetrahydroxyflavan is found in pulses.

Gadoteric acid

1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraaza-13-gadolinatetracyclo[5.5.1.0^{4,13}.0^{10,13}]tridecane-1,4,7,10-tetraium-13-uide

C16H28GdN4O8 (562.1148)

Gadoteric acid, also known as gadoterate, belongs to the class of organic compounds known as tetracarboxylic acids and derivatives. These are carboxylic acids containing exactly four carboxyl groups. Gadoteric acid is considered to be a practically insoluble (in water) and relatively neutral molecule.

(1R,2R)-5,5-Dichloro-N-(1-cyanocyclopropyl)-2-(4-(4-(methylsulfonyl)phenyl)-1-(2,2,2-trifluoroethyl)-1H-pyrazol-3-yl)cyclohexanecarboxamide

(1R,2R)-5,5-Dichloro-N-(1-cyanocyclopropyl)-2-(4-(4-(methylsulphonyl)phenyl)-1-(2,2,2-trifluoroethyl)-1H-pyrazol-3-yl)cyclohexanecarboxamide

C23H23Cl2F3N4O3S (562.082)

8)-catechin

ent-Fisetinidol-(4alpha-

6,7-Dihydro-8-(2,4-dihydroxyphenyl)-6-(3,4-dihydroxyphenyl)-7-hydroxy-8H-pyrano[2,3-f]catechin

(10R)-8,9-Dihydro-10-(2,4-dihydroxyphenyl)-8-(3,4-dihydroxyphenyl)-9-hydroxy-10H-pyrano[2,3-h]catechin

Epioritin-(4beta-

6)-epioritin-4alpha-ol

ent-Oritin-(4beta-

5)-epioritin-4beta-ol

6,7-Dihydro-6-(2,4-dihydroxyphenyl)-8-(3,4-dihydroxyphenyl)-7-hydroxy-8H-pyrano[3,2-g]catechin

6)-robinetinidol

Fisetinidol-(4beta-

Fisetinidol-(4alpha-

6)-fisetinidol-4alpha-ol

Trilobatin A

6)-catechin

ent-Fisetinidol-(4alpha-

(S)-Epiglucoisatisin

C21H26N2O12S2 (562.0927)

8,9-Dihydro-8-(2,4-dihydroxyphenyl)-10-(3,4-dihydroxyphenyl)-9-hydroxy-10H-pyrano[2,3-h]catechin

3,5,7,4-Tetrahydroxyflavan-(4-O-4)-3,5,7,4-tetrahydroxyflavan

3,5,7,4-Tetrahydroxyflavan-(4-

8)-3,4,5,7,4-pentahydroxyflavan

8)-epicatechin

ent-Epiafzelechin-(4alpha-

8)-epiafzelechin

ent-Epicatechin-(4alpha-

Fisetinidol-(4beta-

6)-fisetinidol-4alpha-ol

(6S)-6,7-Dihydro-8-(2,4-dihydroxyphenyl)-6-(3,4-dihydroxyphenyl)-7-hydroxy-8H-pyrano[2,3-f]epicatechin

(6R)-6,7-Dihydro-8-(2,4-dihydroxyphenyl)-6-(3,4-dihydroxyphenyl)-7-hydroxy-8H-pyrano[2,3-f]epicatechin

6,7-Dihydro-8-(2,4-dihydroxyphenyl)-6-(3,4-dihydroxyphenyl)-7-hydroxy-8H-pyrano[2,3-f]-ent-catechin

6,7-Dihydro-6-(2,4-dihydroxyphenyl)-8-(3,4-dihydroxyphenyl)-7-hydroxy-8H-pyrano[3,2-g]epicatechin

(10S)-8,9-Dihydro-10-(2,4-dihydroxyphenyl)-8-(3,4-dihydroxyphenyl)-9-hydroxy-10H-pyrano[2,3-h]catechin

(10R)-8,9-Dihydro-10-(2,4-dihydroxyphenyl)-8-(3,4-dihydroxyphenyl)-9-hydroxy-10H-pyrano[2,3-h]epicatechin

(10S)-8,9-Dihydro-10-(2,4-dihydroxyphenyl)-8-(3,4-dihydroxyphenyl)-9-hydroxy-10H-pyrano[2,3-h]epicatechin

8,9-Dihydro-10-(2,4-dihydroxyphenyl)-8-(3,4-dihydroxyphenyl)-9-hydroxy-10H-pyrano[2,3-h]-ent-catechin

8,9-Dihydro-10-(2,4-dihydroxyphenyl)-8-(3,4-dihydroxyphenyl)-9-hydroxy-10H-pyrano[2,3-h]-ent-epicatechin

(2R,3S,8S,9R,10S)-8-(2,4-Dihydroxyphenyl)-2,10-bis(3,4-dihydroxyphenyl)-3,4,9,10-tetrahydro-2H,8H-benzo[1,2-b:3,4-b鈥樎嘳dipyran-3,5,9-triol

Fisetinidol(4alpha鈥樏傗垎6)mesquitol

(3.4-Dihydroxy-phenyl)-(4.6-dihydroxy-cumaranyl-(2))-[3.5.7-trihydroxy-2-(3.4-dihydroxy-phenyl)-chromanyl-(6)]-methan|<3.4-Dihydroxy-phenyl>-<4.6-dihydroxy-cumaranyl-(2)>-(3.5.7-trihydroxy-2-<3.4-dihydroxy-phenyl>-chromanyl-(6))-methan|Anhydro-dicatechin

(3.4-Dihydroxy-phenyl)-(4.6-dihydroxy-cumaranyl-(2))-[3.5.7-trihydroxy-2-(3.4-dihydroxy-phenyl)-chromanyl-(6)]-methan|<3.4-Dihydroxy-phenyl>-<4.6-dihydroxy-cumaranyl-(2)>-(3.5.7-trihydroxy-2-<3.4-dihydroxy-phenyl>-chromanyl-(6))-methan|Anhydro-dicatechin

gambirflavan D3

gambirflavan D2

butinflavan-(4beta->8)-epigallocatechin

C30H26O11

Cryptoclauxin

C29H22O12 (562.1111)

ent-Fisetinidol-(4alpha->6)-catechin

epicatechin-(3->0->7)-epiafzelechin

morintoside B

SPF-3059-20

C28H18O13 (562.0747)

ent-oritin-(4alpha->4)-epioritin-4alpha-ol

epioritin-(4beta->3)-epioritin-4beta-ol

catechin-(3->0->3)-afzelechin

fargenin D

C25H22O15 (562.0959)

apigenin 7-O-(6-O-p-coumaroyl)glucoside

2,4-O-di<(E)-feruloyl>glucaric acid|2,4-O-di[(E)-feruloyl]glucaric acid

SCHEMBL14286431

C28H18O13 (562.0747)

Leucopelargonidin dimer

2,2-Bis(4-hydroxyphenyl)-4,8-bichroman-3,3,4,5,5,7,7-heptol

Epifisetinidol(4b->8)catechin

2-(3,4-dihydroxyphenyl)-8-[2-(3,4-dihydroxyphenyl)-3,7-dihydroxy-3,4-dihydro-2H-1-benzopyran-4-yl]-3,4-dihydro-2H-1-benzopyran-3,5,7-triol

Physalin H

14-chloro-5,15-dihydroxy-2,9,26-trimethyl-3,19,23,28-tetraoxaoctacyclo[16.9.1.1^{18,27}.0^{1,5}.0^{2,24}.0^{8,17}.0^{9,14}.0^{21,26}]nonacos-11-ene-4,10,22,29-tetrone

C28H31ClO10 (562.1606)

Catechin-(4alpha->8)-epiafzelechin

2-(3,4-dihydroxyphenyl)-4-[3,5,7-trihydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-8-yl]-3,4-dihydro-2H-1-benzopyran-3,5,7-triol

N-[4-(1H,1H,2H,2H-PERFLUORODECYL)BENZYLOXYCARBONYLOXY]SUCCINIMIDE

C16H19F17Si (562.0984)

sodium 6-amino-5-[[3-[(ethylphenylamino)sulphonyl]-4-methylphenyl]azo]-4-hydroxynaphthalene-2-sulphonate

C25H23N4NaO6S2 (562.0957)

2 7-BIS(3-CARBOXYPROPYL)-5(6)-CARBOXY-

3,7-Dibromo-5,5-dioctyl-5H-dibenzo[b,d]silole

C28H40Br2Si (562.1266)

[(2R,5R)-3-acetyloxy-5-[5-(2-amino-3,5-dicyano-6-phenylsulfanylpyridin-4-yl)-2,4-dioxopyrimidin-1-yl]oxolan-2-yl]methyl acetate

C26H22N6O7S (562.1271)

Ziprasidone mesilate

C22H31ClN4O7S2 (562.1323)

D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent

Retagliptin Phosphate

C19H21F6N4O7P (562.1052)

(11β,16α,17α)-9-Chloro-17-(2,2-dioxido-5H-1,2-oxathiol-4-yl)-17-[(2-furanylcarbonyl)oxy]-11-hydroxy-16-Methyl-androsta-1,4-dien-3-one

C28H31ClO8S (562.1428)

CID 86278348

(1-6)-alpha-D-Glucan reduced reaction products with iron hydroxide

C18H34FeO16+3 (562.1196)

(ETHYLTHIO)ACETICACID

C26H28Cl2N4O2S2 (562.1031)

2-(3,4-dihydroxyphenyl)-8-[3,5,7-trihydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2H-chromen-4-yl]-3,4-dihydro-2H-chromene-3,5,7-triol

(1R,2R)-5,5-Dichloro-N-(1-cyanocyclopropyl)-2-(4-(4-(methylsulfonyl)phenyl)-1-(2,2,2-trifluoroethyl)-1H-pyrazol-3-yl)cyclohexanecarboxamide

(1R,2R)-5,5-Dichloro-N-(1-cyanocyclopropyl)-2-(4-(4-(methylsulphonyl)phenyl)-1-(2,2,2-trifluoroethyl)-1H-pyrazol-3-yl)cyclohexanecarboxamide

C23H23Cl2F3N4O3S (562.082)

cyanidin 3-O-(6-O-malyl-beta-D-glucoside)

C25H22O15-2 (562.0959)

3-[18-(2-Carboxylatoethyl)-3,8,13,17-tetramethylporphyrin-21,23-diid-2-yl]propanoate;iron

C30H26FeN4O4-4 (562.1303)

dTDP-4-O-demethyl-beta-L-noviose

[hydroxy-[[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy]phosphoryl] [(2S,3R,4R,5R)-3,4,5-trihydroxy-6,6-dimethyloxan-2-yl] hydrogen phosphate

CID 134819293

C16H28GdN4O8+3 (562.1148)

V - Various > V08 - Contrast media > V08C - Magnetic resonance imaging contrast media > V08CA - Paramagnetic contrast media

Fisetinidol-(4alpha,8)-catechin

A ring assembly that consists of fisetinidol attached to a (+)-catechin unit resulting in a bond between C-4 of the pyran ring and C-8 of the benzopyran ring. It is isolated from Acacia mearnsii.

[1,1,1,3,3,3-Hexafluoro-2-[4-[(4-methylphenyl)sulfonylamino]phenyl]propan-2-yl] 2-nitrobenzoate

C23H16F6N2O6S (562.0633)

[2-[2-Chloro-5-(trifluoromethyl)anilino]-2-oxoethyl] 1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)piperidine-4-carboxylate

C23H22ClF3N2O7S (562.0788)

2-[(1S,3R,4aS,9aR)-6-[(4-fluorophenyl)sulfonylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(2,5-difluorophenyl)methyl]acetamide

2-[(1S,3S,4aS,9aR)-6-[(4-fluorophenyl)sulfonylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(2,5-difluorophenyl)methyl]acetamide

2-[(1R,3R,4aS,9aR)-6-[(4-fluorophenyl)sulfonylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(2,5-difluorophenyl)methyl]acetamide

2-[(1S,3R,4aR,9aS)-6-[(4-fluorophenyl)sulfonylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(2,5-difluorophenyl)methyl]acetamide

2-[(1R,3R,4aR,9aS)-6-[(4-fluorophenyl)sulfonylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(2,5-difluorophenyl)methyl]acetamide

2-[(1R,3S,4aR,9aS)-6-[(4-fluorophenyl)sulfonylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(2,5-difluorophenyl)methyl]acetamide

2-[(1S,3S,4aR,9aS)-6-[(4-fluorophenyl)sulfonylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(2,5-difluorophenyl)methyl]acetamide

2-[(1R,3S,4aS,9aR)-6-[(4-fluorophenyl)sulfonylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(2,5-difluorophenyl)methyl]acetamide

ethyl (2E)-3-oxo-7-phenyl-5-thiophen-2-yl-2-[(3,4,5-trimethoxyphenyl)methylidene]-5H-[1,3]thiazolo[3,2-a]pyrimidine-6-carboxylate

C29H26N2O6S2 (562.1232)

Gambiriin B3

3,3,4,5,7-Pentahydroxyflavan(4->8)-3,4,5,7-tetrahydroxyflavan

IACS-010759

C25H25F3N6O4S (562.161)

IACS-010759 is an orally active, potent mitochondrial complex I of oxidative phosphorylation (OXPHOS) inhibitor. IACS-010759 inhibits proliferation and induces apoptosis in models of brain cancer and acute myeloid leukemia (AML) reliant on OXPHOS. IACS-010759 has the potential for relapsed/refractory AML and solid tumors research[1][2].

(2s,3r,4r)-2-(4-hydroxyphenyl)-6-[(2r,3r,4s)-3,7,8-trihydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-4-yl]-3,4-dihydro-2h-1-benzopyran-3,4,7,8-tetrol

(1s,14s)-5-methyl-3,6-dioxo-4-sulfanylidene-11-oxa-2,5-diazatricyclo[7.5.0.0²,⁷]tetradeca-7,9,12-trien-14-yl 3-(5-formyl-2-methoxyphenoxy)-4-methoxybenzoate

C28H22N2O9S (562.1046)

(1r,2r,21s,23s)-21-acetyl-3,18-dihydroxy-2,7,14,19-tetramethoxy-23-methyl-22,25-dioxaheptacyclo[19.3.1.0¹,¹⁰.0⁴,⁹.0⁸,¹³.0¹¹,²⁰.0¹²,¹⁷]pentacosa-3,6,8,10,12,14,17,19-octaene-5,16-dione

(1r,2r,21s,23s)-21-acetyl-3,18-dihydroxy-2,7,14,19-tetramethoxy-23-methyl-22,25-dioxaheptacyclo[19.3.1.0¹,¹⁰.0⁴,⁹.0⁸,¹³.0¹¹,²⁰.0¹²,¹⁷]pentacosa-3,6,8,10,12,14,17,19-octaene-5,16-dione

(2r,3r,4r)-2-(4-hydroxyphenyl)-6-[(2s,3r,4r)-3,7,8-trihydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-4-yl]-3,4-dihydro-2h-1-benzopyran-3,4,7,8-tetrol

[(2r,3s,4s,5r,6s)-3,4,5-trihydroxy-6-{[5-hydroxy-2-(4-hydroxyphenyl)-4-oxochromen-7-yl]oxy}oxan-2-yl]methyl (2e)-3-phenylprop-2-enoate

[(2r,3s,4s,5r,6s)-3,4,5-trihydroxy-6-{[5-hydroxy-2-(4-hydroxyphenyl)-4-oxochromen-7-yl]oxy}oxan-2-yl]methyl 3-phenylprop-2-enoate

(1r,2s)-3-({[(2r,3r,4s,5s)-2-[(2s)-2-carboxy-2-hydroxyethyl]-4,5-dihydroxyoxan-3-yl]oxy}carbonyl)-1-(3,4-dihydroxyphenyl)-6,7-dihydroxy-1,2-dihydronaphthalene-2-carboxylic acid

2-{3,5-dihydroxy-4-[(phenoxycarbonyl)oxy]phenyl}-5-hydroxy-3,4-dihydro-2h-1-benzopyran-7-yl 3,4,5-trihydroxybenzoate

C29H22O12 (562.1111)

(2r,3s)-2-(3,4-dihydroxyphenyl)-6-[(2r,3s,4s)-2-(3,4-dihydroxyphenyl)-3,7-dihydroxy-3,4-dihydro-2h-1-benzopyran-4-yl]-3,4-dihydro-2h-1-benzopyran-3,5,7-triol

2-(4-hydroxyphenyl)-5-[3,7,8-trihydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-4-yl]-3,4-dihydro-2h-1-benzopyran-3,4,7,8-tetrol

(2r,3r,4s)-2-(4-hydroxyphenyl)-6-[(2r,3r,4s)-3,7,8-trihydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-4-yl]-3,4-dihydro-2h-1-benzopyran-3,4,7,8-tetrol

(2s,3s,4s,5r,6s)-4-[(2-carboxyacetyl)oxy]-3,5-dihydroxy-6-{[5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4-oxochromen-7-yl]oxy}oxane-2-carboxylic acid

C25H22O15 (562.0959)

(2r,3r,4r)-2-(4-hydroxyphenyl)-5-[(2r,3r,4s)-3,7,8-trihydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-4-yl]-3,4-dihydro-2h-1-benzopyran-3,4,7,8-tetrol

2-(4-hydroxyphenyl)-4-{[4,7,8-trihydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3-yl]oxy}-3,4-dihydro-2h-1-benzopyran-3,7,8-triol

(2r,3s)-2-(3,4-dihydroxyphenyl)-8-[(2r,3s,4s)-2-(3,4-dihydroxyphenyl)-3,7-dihydroxy-3,4-dihydro-2h-1-benzopyran-4-yl]-3,4-dihydro-2h-1-benzopyran-3,5,7-triol

5-methyl-3,6-dioxo-4-sulfanylidene-11-oxa-2,5-diazatricyclo[7.5.0.0²,⁷]tetradeca-7,9,12-trien-14-yl 3-(5-formyl-2-methoxyphenoxy)-4-methoxybenzoate

C28H22N2O9S (562.1046)

[(z)-[(3r)-3-({2-[(3s)-2-hydroxy-3h-indol-3-yl]acetyl}oxy)-1-{[(2r,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}pent-4-en-1-ylidene]amino]oxysulfonic acid

C21H26N2O12S2 (562.0927)

2-(3,4-dihydroxyphenyl)-8-[2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3,4-dihydro-2h-1-benzopyran-4-yl]-3,4-dihydro-2h-1-benzopyran-3,5,7-triol

(2r,3r,4r)-2-(4-hydroxyphenyl)-6-[(2r,3r,4s)-3,7,8-trihydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-4-yl]-3,4-dihydro-2h-1-benzopyran-3,4,7,8-tetrol

4-[2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-3,4-dihydro-2h-1-benzopyran-8-yl]-2-(4-hydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3,5,7-triol

(2s,3r,4s,5s,6r)-4,5-dihydroxy-2-[5-hydroxy-2-(4-hydroxyphenyl)-4-oxochromen-7-yl]-6-(hydroxymethyl)oxan-3-yl (2e)-3-(4-hydroxyphenyl)prop-2-enoate

(2r,3s)-2-(3,4-dihydroxyphenyl)-6-[(2r,3s,4s)-2-(3,4-dihydroxyphenyl)-3,7-dihydroxy-3,4-dihydro-2h-1-benzopyran-4-yl]-3,4-dihydro-2h-1-benzopyran-3,7,8-triol

(1s,2s,21r,23s)-21-acetyl-3,18-dihydroxy-2,7,14,19-tetramethoxy-23-methyl-22,25-dioxaheptacyclo[19.3.1.0¹,¹⁰.0⁴,⁹.0⁸,¹³.0¹¹,²⁰.0¹²,¹⁷]pentacosa-3,6,8,10,12,14,17,19-octaene-5,16-dione

(1s,2s,21r,23s)-21-acetyl-3,18-dihydroxy-2,7,14,19-tetramethoxy-23-methyl-22,25-dioxaheptacyclo[19.3.1.0¹,¹⁰.0⁴,⁹.0⁸,¹³.0¹¹,²⁰.0¹²,¹⁷]pentacosa-3,6,8,10,12,14,17,19-octaene-5,16-dione